Lazard Asset Management’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.9M | Sell |
131,734
-18,392
| -12% | -$3.87M | 0.04% | 294 |
|
|
2025
Q4 | $29.8M | Buy |
150,126
+2,793
| +2% | +$564K | 0.05% | 258 |
|
|
2025
Q3 | $29.9M | Buy |
147,333
+35,936
| +32% | +$6.38M | 0.04% | 254 |
|
|
2025
Q2 | $19.6M | Buy |
111,397
+28,431
| +34% | +$4.28M | 0.03% | 413 |
|
|
2025
Q1 | $11.2M | Buy |
82,966
+12,971
| +19% | +$1.71M | 0.02% | 464 |
|
|
2024
Q4 | $8.83M | Buy |
69,995
+61,720
| +746% | +$9.18M | 0.01% | 492 |
|
|
2024
Q3 | $1.37M | Sell |
8,275
-4,947
| -37% | -$748K | ﹤0.01% | 976 |
|
|
2024
Q2 | $1.76M | Buy |
+13,222
| New | +$1.59M | ﹤0.01% | 872 |
|
|
2024
Q1 | – | Sell |
-7,396
| Closed | -$558K | – | 2370 |
|
|
2023
Q4 | $558K | Sell |
7,396
-24
| -0.3% | -$1.52K | ﹤0.01% | 1081 |
|
|
2023
Q3 | $488K | Buy |
7,420
+5,626
| +314% | +$421K | ﹤0.01% | 1152 |
|
|
2023
Q2 | $145K | Sell |
1,794
-248,320
| -99% | -$17.7M | ﹤0.01% | 1442 |
|
|
2023
Q1 | $14.9M | Sell |
250,114
-70,943
| -22% | -$3.94M | 0.02% | 498 |
|
|
2022
Q4 | $15.7M | Sell |
321,057
-3,067
| -0.9% | -$142K | 0.02% | 481 |
|
|
2022
Q3 | $16.7M | Buy |
324,124
+196,949
| +155% | +$11.7M | 0.02% | 450 |
|
|
2022
Q2 | $6.68M | Buy |
127,175
+126,750
| +29,824% | +$8.82M | 0.01% | 682 |
|
|
2022
Q1 | $36K | Buy |
+425
| New | +$34.9K | ﹤0.01% | 1902 |
|
|
2021
Q4 | – | Sell |
-42,257
| Closed | -$2.81M | – | 2460 |
|
|
2021
Q3 | $2.81M | Buy |
+42,257
| New | +$3M | ﹤0.01% | 869 |
|
|
2020
Q2 | – | Sell |
-29,090
| Closed | -$418K | – | 1781 |
|
|
2020
Q1 | $418K | Hold |
29,090
| – | – | ﹤0.01% | 823 |
|
|
2019
Q4 | $1.11M | Hold |
29,090
| – | – | ﹤0.01% | 741 |
|
|
2019
Q3 | $643K | Hold |
29,090
| – | – | ﹤0.01% | 793 |
|
|
2019
Q2 | $600K | Sell |
29,090
-3,500
| -11% | -$80.7K | ﹤0.01% | 918 |
|
|
2019
Q1 | $939K | Buy |
32,590
+13,390
| +70% | +$331K | ﹤0.01% | 854 |
|
|
2018
Q4 | $329K | Hold |
19,200
| – | – | ﹤0.01% | 825 |
|
|
2018
Q3 | $546K | Buy |
+19,200
| New | +$634K | ﹤0.01% | 806 |
|
|
2017
Q4 | – | Sell |
-1,315
| Closed | -$21K | – | 1109 |
|
|
2017
Q3 | $21K | Buy |
1,315
+1,106
| +529% | +$18.8K | ﹤0.01% | 885 |
|
|
2017
Q2 | $4K | Buy |
+209
| New | +$3.65K | ﹤0.01% | 963 |
|
|
2015
Q2 | – | Sell |
-550
| Closed | -$27K | – | 1181 |
|
|
2015
Q1 | $27K | Buy |
+550
| New | +$25.7K | ﹤0.01% | 1017 |
|
|
2014
Q2 | – | Sell |
-20,894
| Closed | -$894K | – | 1062 |
|
|
2014
Q1 | $894K | Hold |
20,894
| – | – | ﹤0.01% | 689 |
|
|
2013
Q4 | $880K | Hold |
20,894
| – | – | ﹤0.01% | 716 |
|
|
2013
Q3 | $860K | Hold |
20,894
| – | – | ﹤0.01% | 702 |
|
|
2013
Q2 | $963K | Buy |
+20,894
| New | +$936K | ﹤0.01% | 706 |
|
Other funds holding THC
VPM
VCM
LPC
Lazard Asset Management's THC Position: Q1 2026 in Review
Lazard Asset Management reduced its Tenet Healthcare (THC) stake by 12% in Q1 2026, selling an estimated $3.87M and leaving 131,734 shares worth $24.9M. The position accounts for 0.04% of the portfolio, ranked #294.
Lazard Asset Management first reported a position in THC in Q2 2013 and has held it in 31 quarters since. The position peaked at $29.9M in Q3 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Lazard Asset Management held 131,734 shares of Tenet Healthcare worth $24.9M as of Q1 2026.
- Lazard Asset Management sold 18,392 Tenet Healthcare shares in Q1 2026, an estimated $3.87M.
- Tenet Healthcare made up 0.04% of Lazard Asset Management's portfolio in Q1 2026, its #294 holding.
- Lazard Asset Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 31 quarters since.
- Lazard Asset Management's Tenet Healthcare position peaked at $29.9M in Q3 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.